Virax Biolabs Group Ltd (VRAX) stock
VRAXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends March 31
$0.43−0.02 (-3.39%)
Close on Nov 18, 2026Market cap $249.06KP/E –Yield –
Virax Biolabs shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2026 it was 0M, up 166.5% from the year before. The highest annual figure on record is 0M in fiscal 2026.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | 0M | +166.5% |
| FY2025 | Mar 31, 2025 | 0M | +85.9% |
| FY2024 | Mar 31, 2024 | 0M | +88.8% |
| FY2023 | Mar 31, 2023 | 0M | +11.2% |
| FY2022 | Mar 31, 2022 | 0M | +61.3% |
| FY2021 | Mar 31, 2021 | 0M | – |
See a number that looks wrong?